Renexxion Ireland Innovation
There is a large unmet medical need for patients with disorders of gastrointestinal motility. Naronapride, a late-development stage, Phase-3 ready, oral gastro-prokinetic, 5-HT4 agonist has shown efficacy in a wide range of these disorders.
It is estimated that at least 16% of people worldwide suffer from GI-related disorders. Currently approved therapies do not completely address this high therapeutic need. In some cases, there are no approved therapies. Naronapride has the potential to address the major GI indications associated with dysmotility including chronic idiopathic constipation (CIC), irritable bowel syndrome - constipation type (IBSc), functional dyspepsia (FD), gastroparesis (GP), and gastro-esophageal reflux disease (GERD), in particular PPI-resistant GERD where chronic oral treatments are required.
Naronapride may also address unmet therapeutic needs in smaller GI-related indications, both chronic and acute. These include Enteral Feeding Intolerance (EFI), acute GP, short bowel syndrome (SBS), and post-operative ileus (POI).
Company Details
- Employees
- 11
- Address
- Dungar House, Roscrea,co. Tipperary E53 N220,ireland
- Phone
- +1 650 924 9895
- bd****@****ion.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- renexxion.com
- HQ
- Roscrea, Co. Tipperary
Renexxion Ireland Ltd Questions
Renexxion Ireland Ltd's helpline number is +1 650 924 9895
Renexxion Ireland Ltd's website is renexxion.com
Renexxion Ireland Ltd's LinkedIn profile is https://ie.linkedin.com/company/renexxion
Renexxion Ireland Ltd has
11 employees.
View email and phone details for 11
employees at Renexxion Ireland Ltd.
Renexxion Ireland Ltd's industry is
Pharmaceutical Manufacturing
Renexxion Ireland Ltd's top competitors are
Cylaros,
Ambrose Health,
Signon (Eu Project),
Huntington's Disease Association Of Ireland,
Polk Institute Foundation,
Sentio Ergo Sum,
Dr. Falk Pharma,
Unlock Pacific Ventures,
Xyra,
Levels Of Strength Llc.
Renexxion Ireland Ltd's support email address is bd@renexxion.com
Renexxion Ireland Ltd's categories are Pharmaceutical Manufacturing
